Cargando…
Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study
PURPOSE: Familial papillary thyroid microcarcinoma (FPTMC) can present a more aggressive behavior than the sporadic microcarcinoma. However, few studies have analyzed this situation. The objective is to analyze the recurrence rate of FPTMC and the prognostic factors which determine that recurrence i...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722874/ https://www.ncbi.nlm.nih.gov/pubmed/36251077 http://dx.doi.org/10.1007/s00423-022-02704-4 |
_version_ | 1784844052346175488 |
---|---|
author | Ríos, A. Rodríguez, M. A. Puñal, J. A. Moreno, P. Mercader, E. Ferrero, E. Ruiz-Pardo, J. Morlán, M. A. Martín, J. Durán-Poveda, M. Bravo, J. M. Casanova, D. Egea, M. P. Salvador Torregrosa, N. M. Exposito-Rodríguez, A. Martínez-Fernández, G. Carrión, A. M. Vidal, O. Herrera, F. Ruiz-Merino, G. Rodríguez, J. M. |
author_facet | Ríos, A. Rodríguez, M. A. Puñal, J. A. Moreno, P. Mercader, E. Ferrero, E. Ruiz-Pardo, J. Morlán, M. A. Martín, J. Durán-Poveda, M. Bravo, J. M. Casanova, D. Egea, M. P. Salvador Torregrosa, N. M. Exposito-Rodríguez, A. Martínez-Fernández, G. Carrión, A. M. Vidal, O. Herrera, F. Ruiz-Merino, G. Rodríguez, J. M. |
author_sort | Ríos, A. |
collection | PubMed |
description | PURPOSE: Familial papillary thyroid microcarcinoma (FPTMC) can present a more aggressive behavior than the sporadic microcarcinoma. However, few studies have analyzed this situation. The objective is to analyze the recurrence rate of FPTMC and the prognostic factors which determine that recurrence in Spain. METHODS: Spanish multicenter longitudinal analytical observational study was conducted. Patients with FPTMC received treatment with curative intent and presented cure criteria 6 months after treatment. Recurrence rate and disease-free survival (DFS) were analyzed. Two groups were analyzed: group A (no tumor recurrence) vs. group B (tumor recurrence). RESULTS: Ninety-four patients were analyzed. During a mean follow-up of 73.3 ± 59.3 months, 13 recurrences of FPTMC (13.83%) were detected and mean DFS was 207.9 ± 11.5 months. There were multifocality in 56%, bilateral thyroid involvement in 30%, and vascular invasion in 7.5%; that is to say, they are tumors with histological factors of poor prognosis in a high percentage of cases. The main risk factors for recurrence obtained in the multivariate analysis were the tumor size (OR: 2.574, 95% CI 1.210–5.473; p = 0.014) and the assessment of the risk of recurrence of the American Thyroid Association (ATA), both intermediate risk versus low risk (OR: 125, 95% CI 10.638–1000; p < 0.001) and high risk versus low risk (OR: 45.454, 95% CI 5.405–333.333; p < 0.001). CONCLUSION: FPTMC has a recurrence rate higher than sporadic cases. Poor prognosis is mainly associated with the tumor size and the risk of recurrence of the ATA. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-9722874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-97228742022-12-07 Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study Ríos, A. Rodríguez, M. A. Puñal, J. A. Moreno, P. Mercader, E. Ferrero, E. Ruiz-Pardo, J. Morlán, M. A. Martín, J. Durán-Poveda, M. Bravo, J. M. Casanova, D. Egea, M. P. Salvador Torregrosa, N. M. Exposito-Rodríguez, A. Martínez-Fernández, G. Carrión, A. M. Vidal, O. Herrera, F. Ruiz-Merino, G. Rodríguez, J. M. Langenbecks Arch Surg Original Article PURPOSE: Familial papillary thyroid microcarcinoma (FPTMC) can present a more aggressive behavior than the sporadic microcarcinoma. However, few studies have analyzed this situation. The objective is to analyze the recurrence rate of FPTMC and the prognostic factors which determine that recurrence in Spain. METHODS: Spanish multicenter longitudinal analytical observational study was conducted. Patients with FPTMC received treatment with curative intent and presented cure criteria 6 months after treatment. Recurrence rate and disease-free survival (DFS) were analyzed. Two groups were analyzed: group A (no tumor recurrence) vs. group B (tumor recurrence). RESULTS: Ninety-four patients were analyzed. During a mean follow-up of 73.3 ± 59.3 months, 13 recurrences of FPTMC (13.83%) were detected and mean DFS was 207.9 ± 11.5 months. There were multifocality in 56%, bilateral thyroid involvement in 30%, and vascular invasion in 7.5%; that is to say, they are tumors with histological factors of poor prognosis in a high percentage of cases. The main risk factors for recurrence obtained in the multivariate analysis were the tumor size (OR: 2.574, 95% CI 1.210–5.473; p = 0.014) and the assessment of the risk of recurrence of the American Thyroid Association (ATA), both intermediate risk versus low risk (OR: 125, 95% CI 10.638–1000; p < 0.001) and high risk versus low risk (OR: 45.454, 95% CI 5.405–333.333; p < 0.001). CONCLUSION: FPTMC has a recurrence rate higher than sporadic cases. Poor prognosis is mainly associated with the tumor size and the risk of recurrence of the ATA. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2022-10-17 2022 /pmc/articles/PMC9722874/ /pubmed/36251077 http://dx.doi.org/10.1007/s00423-022-02704-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Ríos, A. Rodríguez, M. A. Puñal, J. A. Moreno, P. Mercader, E. Ferrero, E. Ruiz-Pardo, J. Morlán, M. A. Martín, J. Durán-Poveda, M. Bravo, J. M. Casanova, D. Egea, M. P. Salvador Torregrosa, N. M. Exposito-Rodríguez, A. Martínez-Fernández, G. Carrión, A. M. Vidal, O. Herrera, F. Ruiz-Merino, G. Rodríguez, J. M. Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study |
title | Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study |
title_full | Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study |
title_fullStr | Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study |
title_full_unstemmed | Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study |
title_short | Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study |
title_sort | biological behavior of familial papillary thyroid microcarcinoma: spanish multicenter study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722874/ https://www.ncbi.nlm.nih.gov/pubmed/36251077 http://dx.doi.org/10.1007/s00423-022-02704-4 |
work_keys_str_mv | AT riosa biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT rodriguezma biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT punalja biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT morenop biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT mercadere biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT ferreroe biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT ruizpardoj biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT morlanma biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT martinj biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT duranpovedam biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT bravojm biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT casanovad biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT egeampsalvador biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT torregrosanm biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT expositorodrigueza biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT martinezfernandezg biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT carrionam biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT vidalo biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT herreraf biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT ruizmerinog biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy AT rodriguezjm biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy |